MedPath

NEOSTIGMINE METHYLSULFATE INJECTION USP

NEOSTIGMINE METHYLSULFATE INJECTION USP

Approved
DIN Number

02497786

Drug Class

Human

Market Date

N/A

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02497786
AIG Number0102263003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07AA01 NEOSTIGMINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intramuscular ,  Intravenous
AHFS Classification12:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

NEOSTIGMINE METHYLSULFATEActive
Strength: 1 MG / ML
Monograph: NEOSTIGMINE METHYLSULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.